Galapagos | GLPG - Dochód Netto

Cena Akcji
28.82
Dzienna Zmiana
0.20 0.70%
Miesięcznie
2.27%
Rocznie
17.06%
Q1 Prognozy TE
27.72




Dochód Netto Zmiana Data
argenx SE USD 532.95M 188.69M 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Biogen USD 466.5M 168.3M 2025-09
Genmab DKK 336M 141M 2025-06
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
GRIFOLS EUR 98.25M 28.72M 2025-12
Hikma Pharmaceutical USD 164M 45M 2025-12
Incyte USD 299.28M 124.89M 2025-12
Merck EUR 902M 250M 2025-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 3.93B 96M 2025-09
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR -801M 3.6B 2025-12
UCB EUR 857M 649M 2024-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12